Status:
UNKNOWN
Gut Microbiome Modification Through Dietary Intervention in Patients With Colorectal Cancer: Response to Surgery
Lead Sponsor:
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Conditions:
Colorectal Cancer
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The investigators will conduct an open, controlled, randomized clinical trial, in patients with scheduled surgical intervention for CRC in the General Surgery and Digestive System Unit of the Virgen d...
Eligibility Criteria
Inclusion
- Age between 18-80 years old.
- After clinical diagnosis of CRC (stage I-III), the doctor has recommended and arranged for CRC surgery
Exclusion
- Clinical diagnosis of stage IV CRC.
- Current gastrointestinal illness other than gastroesophageal reflux disease or hemorrhoids (such as celiac disease, inflammatory bowel disease, malabsorptive bariatric procedures, etc.).
- Chronic liver or kidney disease.
- History of cardiac disease.
- Positive genetic test for inherited polyposis syndromes (such as familial adenomatous polyps, hereditary non-polyposis colon cancer syndromes, etc).
- Alcoholism or illicit drug use.
- Antibiotic use within the past 2 months.
- Dietary supplement use including pre- or probiotics within the past month.
- History of intestinal cancer, inflammatory bowel disease, celiac disease, or malabsorptive bariatric surgery.
- Inflammatory or connective tissue disease (such as lupus, scleroderma, rheumatoid arthritis, etc.).
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04869956
Start Date
June 1 2021
End Date
June 1 2023
Last Update
July 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Biomedical Research Institute of Murcia (IMIB-Arrixaca)
Murcia, Spain, 30120